Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progressionZhang Li, Yuexiang Wang, Xiaoxiao Liu et al.|Carcinogenesis|2019Cited by 25
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinomaSimin Wang, Yuexiang Wang|EMBO Molecular Medicine|2024Cited by 21